‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification

🇿🇦 Health Policy Watch (ZA) —
‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification

AI Summary

Afrigen Biologics in South Africa has received Good Manufacturing Practice certification for its mRNA vaccine facility in Cape Town, becoming the first African facility certified to manufacture investigational biological products for clinical trials. This marks a significant milestone in vaccine manufacturing capabilities in Africa.

Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […]

World Health Afrigen Biologics mRNA vaccine Good Manufacturing Practice Cape Town clinical trials vaccine manufacturing Africa

Read original source →